Glumetinib Combined With Toripalimab in the Treatment of Relapsed or Metastatic Non-small Cell Lung Cancer.

NCT04797702 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

67

Enrollment

OTHER

Sponsor class

Conditions

Relapsed or Metastatic Non-small Cell Lung Cancer

Interventions

COMBINATION_PRODUCT: Glumetinib combined with Toripalimab

Sponsor

Shanghai Junshi Bioscience Co., Ltd.